EU gives green light to Teva/Cephalon
Modafinil - marketed by Cephalon as Provigil (Credit: Calvero/ Wikimedia Commons)
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Subscribe now